Month: July 2026

Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) —  Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen–derived treatments for Alcohol Use Disorder (“AUD”), addiction, and weight management, today announced the filing of a patent application with the Hong Kong Patent Office for innovative psychedelic compounds targeting the treatment of Post-Traumatic Stress Disorder (“PTSD”) and other mental health disorders.

The U.S. Urology Devices Market is projected to reach USD 29.58 Billion by 2035, while Europe is expected to achieve USD 20.80 Billion, supported by rising demand for robotic-assisted surgery, kidney disease treatment, and advanced urology devices.

The U.S. Urology Devices Market is projected to reach USD 29.58 Billion by 2035, while Europe is expected to achieve USD 20.80 Billion, supported by rising demand for robotic-assisted surgery, kidney disease treatment, and advanced urology devices.

LAS VEGAS, July 20, 2026 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc.^® (OTC: GLXZ), the world’s leading independent developer and distributor of casino table games and technology announced today that, as previously announced, Galaxy Gaming, Inc., a Nevada corporation (“Galaxy”), Evolution Malta Holding Limited, a company registered in Malta (“Evolution”), and Galaga Merger Sub, Inc., a Nevada corporation and a wholly owned subsidiary of Evolution, entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”), pursuant to which Merger Sub will be merged with and into Galaxy, with Galaxy surviving as a wholly owned subsidiary of Evolution (the “Merger”).

Sinai Health’s Schwartz Reisman Emergency Medicine Institute (SREMI) has received a transformational donation from The Gerald Schwartz & Heather Reisman Foundation to address pressing challenges in Canadian emergency departments.

Sinai Health’s Schwartz Reisman Emergency Medicine Institute (SREMI) has received a transformational donation from The Gerald Schwartz & Heather Reisman Foundation to address pressing challenges in Canadian emergency departments.

RT Extends KeepZone’s Exclusive Appointment as Its Representative in Canada and Mexico

The U.S. Stethoscope Market is projected to grow from USD 182.7 Million in 2025 to USD 314.2 Million by 2035, while Europe is expected to expand from USD 199.36 Million to USD 333.78 Million, supported by growing adoption of AI-enabled digital stethoscopes, remote patient monitoring, telemedicine integration, and cardiovascular diagnostics.

The U.S. Stethoscope Market is projected to grow from USD 182.7 Million in 2025 to USD 314.2 Million by 2035, while Europe is expected to expand from USD 199.36 Million to USD 333.78 Million, supported by growing adoption of AI-enabled digital stethoscopes, remote patient monitoring, telemedicine integration, and cardiovascular diagnostics.

Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program clinical starts

Agreement marks the Company’s first direct-to-consumer e-commerce channel outside the United States, advancing the Company’s global commercialization strategy

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months

Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Regulatory Submissions for Future Commercial Supply.

The two companies plan to combine capital markets, energy infrastructure, engineering and construction, and industry resources to pursue the opportunity presented by the rapid growth of the U.S. artificial intelligence industry, with the goal of developing, financing, constructing and operating AI data center projects.

BASEL, Switzerland – July 20, 2026 – Nouscom, a clinical-stage biotech company developing next-generation immunotherapies to treat cancer at all stages, from early cancer interception to late-stage metastatic disease, today announced that new data from its Phase 1b/2 trial of NOUS-209 in Lynch Syndrome (LS) carriers have been accepted for an oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23–27 in Madrid, Spain.

The ColestZen Official Store has introduced ColestZen, a dietary supplement formulated with ingredients selected to support healthy cholesterol levels, help maintain blood sugar levels already within the normal range, and contribute to everyday wellness as part of a balanced lifestyle.

The ColestZen Official Store has introduced ColestZen, a dietary supplement formulated with ingredients selected to support healthy cholesterol levels, help maintain blood sugar levels already within the normal range, and contribute to everyday wellness as part of a balanced lifestyle.

LXP Industrial Trust shareholders to receive $61.20 per share in cash

20th July 2026 – Fleet utilisation for June 2026 was 80%.  

       

STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following clinical updates on FLAMINGO-01.

U.S. Cooling Fabrics Market to Reach USD 1.51 Billion by 2035, While Europe to Grow to USD 1.49 Billion, Led by Sustainable Textile Innovation

U.S. Cooling Fabrics Market to Reach USD 1.51 Billion by 2035, While Europe to Grow to USD 1.49 Billion, Led by Sustainable Textile Innovation